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Dr Angeliki Vouyouka (New York, NY): The paper was very
interesting, but I have a few questions.
From the data that you show us here, the obese class I and the
overweight patients compared to the normal and the underweight,
they appeared to be healthier. They were more likely to be diabetic
and hypertensive; however, they were less likely to be smokers, they
have better ASA risk class, and they were less likely to have COPD.
So do you think that part of your observation reflects some
selection bias among the surgeons, since they were all elective
cases, and therefore when they had to operate on obese patients
they chose the ones that they were in best health as compared to
the rest of them?
Secondly, you have insinuated the answer of this question, but
for better clarification, what percentage of the obese patients had
endovascular procedures, as compared to normal weight and un-
derweight?
And thirdly, again, in the same spirit with the first question, in
this data the obese patients, obese class I, and the overweight, they
did have higher albumin levels, a fact that again perhaps reflects
some selection bias. Do we know patients with low preoperative
serum albumin, obese or overweight, how they did compare to the
ones with high levels of serum albumin?
I want again to thank the committee for the privilege to
discuss this very interesting paper.
Dr Eleftherios Xenos: To answer the second question, we
don’t have a breakdown between endovascular versus open repair
of aneurysms. There is a procedure category that was labeled other
and comprised approximately 30% of the patients. It included thedon’t have an exact number of how many people had an endovas-
cular versus open general vascular procedure.
And I agree with the observation that there might very well be
a selection bias where relatively healthy obese subjects were offered
an operation and very sick morbidly obese patients were denied an
operation and that might be partially responsible for what we see.
Dr Martin Veller (Johannesburg, South Africa): Many of the
individuals we treat with a low BMI have such a low BMI as a result
of an underlying chronic disease. Were you in any way able to look
at this in your study? For example, were the serum albumin levels
helpful in differentiating those individuals with a low BMI as a
result of a chronic disease from those with a low BMI without a
chronic disease?
Dr Xenos: Yes, indeed, it does seem that if somebody is
underweight, he’s underweight for a reason. Many of our risk
factors were highest in underweight patients including dissemi-
nated cancer and recent weight loss. There was also a higher
incidence of patients with COPD. There was, however, no single
etiology for being underweight and having chronic disease.
Dr Starros Kakkos (Detroit, MI): Do you think that slightly
overweight people are naturally selected to be more resistant to
trauma or similar conditions, like surgery?
Dr Xenos: I think it is hard to tell. In our study population,
moderate overweight and obese I type patients had the least
amount of risk factors.
Dr Kakkos: Probably because the definition and grades of
obesity are based on survival statistics.
Dr Xenos: Yes, that is true, the patients were stratified accord-
ing to their BMI, not survival statistics.
